Medication info
Diodipin Tablet 5/80 mg

Diodipin Tablet 5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets (10 tablets per PTP x 3)
Approval status
Active

MFDS item code 201507288 · Approved 2015.10.22 · Insurance code 656004010

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy with the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with either amlodipine or valsartan as monotherapy. It helps lower blood pressure more effectively when existing single therapies are insufficient. This contributes to reducing the risk of cardiovascular diseases caused by hypertension and helps maintain healthy blood pressure.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy with the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This drug should not be used during the second and third trimesters of pregnancy as it may cause serious harm to the fetus and newborn. Patients with hypersensitivity to this drug, pregnant or breastfeeding women, and patients with severe kidney or liver diseases should not take this medication. Care should be taken when administering to patients with specific conditions such as sodium or fluid depletion, hyperkalemia, renal artery stenosis, etc., and blood pressure and renal function should be closely monitored. Various side effects such as dizziness, headache, edema, hypotension, and skin rashes may occur during treatment; consult a physician if any unusual symptoms appear. Dizziness or fatigue may arise during driving or operating machinery; caution is required. When used in conjunction with other medications, interactions may alter effectiveness or increase the risk of side effects, so inform healthcare providers of any medications being taken. Women who are pregnant or planning to become pregnant should not use this drug, and breastfeeding women should also avoid this medication. The safety and efficacy in children under 18 have not been sufficiently established, and use is not recommended. Overdosage may lead to hypotension, dizziness, cardiac issues, etc., so the prescribed dosage must be strictly followed, and seek medical assistance immediately if unusual symptoms occur.

Side effects

Pharyngitis, Influenza, Hypersensitivity, Visual impairment, Anxiety, Headache, Dizziness, Drowsiness, Positional dizziness, Paresthesia, Vertigo, Tinnitus, Tachycardia, Palpitations, Syncope, Orthostatic hypotension, Hypotension, Cough, Pharyngeal and laryngeal pain, Diarrhea, Nausea, Abdominal pain, Constipation, Dry mouth, Rash, Erythema, Hyperhidrosis, Itching, Rash, Joint swelling, Back pain, Arthritis, Muscle spasms, Lethargy, Polyuria, Diabetes, Erectile dysfunction, Edema, Localized edema, Facial edema, Peripheral edema, Fatigue, Flushing, Muscle weakness, Facial flushing, Decreased hemoglobin, Decreased hematocrit, Neutropenia, Thrombocytopenia, Serum sickness including hypersensitivity, Increased serum potassium, Vasculitis, Elevated liver function tests, Angioedema, Vesicular dermatitis, Myalgia, Renal failure, Kidney damage, Increased serum creatinine, Insomnia, Decreased libido, Pharyngitis, Rhinitis, Sinusitis, Upper respiratory tract infection, Viral infection, Diplopia, Thrombocytopenia, Leukopenia, Allergic reaction, Hyperglycemia, Insomnia, Mood changes, Tremor, Sensory decrease, Taste disturbance, Peripheral neuropathy, Hypertonic muscle syndrome, Arrhythmia, Bradycardia, Atrial fibrillation, Ventricular tachycardia, Myocardial infarction, Vasculitis, Dyspnea, Rhinitis, Vomiting, Dyspepsia, Pancreatitis, Gastritis, Gingival hyperplasia, Hepatitis, Jaundice, Alopecia, Purpura, Skin depigmentation, Photosensitivity reaction, Angioedema, Urticaria, Erythema multiforme, Stevens-Johnson syndrome, Myalgia, Urinary disorders, Nocturia, Gynecomastia, Pain, Apathy, Chest pain, Weight loss, Weight gain, Elevated liver enzymes, Chest pain, Weight gain, Arthralgia, Skeletal pain, Rhabdomyolysis, Gingival hyperplasia, Gastritis, Nervous irritability, Sensory decrease, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is susceptible to air and humidity, so it must be stored in a tightly sealed container. It is best to maintain room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets (10 tablets per PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.